{"id":1416,"date":"2022-10-04T16:18:35","date_gmt":"2022-10-04T14:18:35","guid":{"rendered":"https:\/\/biotechaustria.org\/?post_type=mitglieder&#038;p=1416"},"modified":"2023-03-20T23:57:17","modified_gmt":"2023-03-20T22:57:17","slug":"cutanos-gmbh","status":"publish","type":"mitglieder","link":"https:\/\/biotechaustria.org\/en\/mitglieder\/cutanos-gmbh\/","title":{"rendered":"Cutanos GmbH"},"content":{"rendered":"<p>Das Max-Planck-Spin-Off Cutanos entwickelt antigenspezifischer Impfstoffe und innovative Therapien f\u00fcr Autoimmunerkrankungen. Finanzielle Unterst\u00fctzung erf\u00e4hrt Cutanos durch ein internationales Investitionskonsortium, einem Pfizer ESF Grant sowie durch AWS und FFG Grants.<\/p>\n","protected":false},"featured_media":1532,"parent":0,"template":"","class_list":["post-1416","mitglieder","type-mitglieder","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/mitglieder\/1416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/mitglieder"}],"about":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/types\/mitglieder"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/media\/1532"}],"wp:attachment":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/media?parent=1416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}